Tablets 200mg, 400mg, 600mg
M/R tablets 800mg
Liquid 100mg/5mL

 Solution for infusion 400mg/100mL

Tablets 250mg, 500mg
Effervescent tablets 250mg

Evidence suggests that naproxen is aassociated with a lower cardiovascular risk than COX-2 inhibitors, diclofenac or high dose ibuprofen.
naproxen is the preferred option for patients requiring long-term treatment with a more potent NSAID than ibuprofen

Tablets 60mg, 90mg, 120mg

Rheumatology initiation only

Suppositories 12.5mg, 25mg, 50mg, 100mg

For short term treatment of post-op pain, renal colic and lithotripsy only

Tablets e/c 25mg, 50mg
Dispersible tablets 50mg
 
For short term use in breastfeeding mothers only

For short term treatment of post-op pain (Akis^®)
 

Injection 75mg/1mL

Morecambe bay only